Publicaciones en colaboración con investigadoras/es de Hospital Universitario La Paz (10)

2024

  1. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology

2022

  1. Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice

    Anales de Pediatria, Vol. 97, Núm. 2, pp. 130.e1-130.e7

2021

  1. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects

    Liver International, Vol. 41, Núm. 9, pp. 2076-2086

2020

  1. Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25) (Journal of Hepatology (2020) 73(1) (17–25), (S0168827820301276), (10.1016/j.jhep.2020.02.028))

    Journal of Hepatology

  2. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

    Journal of Hepatology, Vol. 73, Núm. 1, pp. 17-25

2018

  1. Ibero-American consensus on low- and no-calorie sweeteners: Safety, nutritional aspects and benefits in food and beverages

    Nutrients, Vol. 10, Núm. 7

  2. Optimal concentration range of golimumab in patients with axial spondyloarthritis

    Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 110-114

2015

  1. Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases

    Clinical Chemistry and Laboratory Medicine

2014

  1. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling

    Hepatology, Vol. 59, Núm. 5, pp. 1972-1983

2000

  1. Prevalence of HTLV infection in pregnant women in Spain

    Sexually Transmitted Infections, Vol. 76, Núm. 5, pp. 366-370